Ind-Swift Laboratories Limited (INDSWFTLAB.NS)
INR 105.01
(-1.58%)
INR 105.01
(-1.58%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.5 Billion | 1.94 Billion | 1.5 Billion | 1.34 Billion | 1.25 Billion | -642.66 Million |
| Net Income | 4.2 Billion | 1.13 Billion | 125.32 Million | 180.08 Million | -197.71 Million | -238.3 Million |
| Depreciation & Amortization | 533.02 Million | 573.62 Million | 1.31 Billion | 872.91 Million | 900.59 Million | 1.04 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4.89 Billion | -513.25 Million | -879.16 Million | -624.08 Million | -310.12 Million | -2.26 Billion |
| Other non-cash items | -1.48 Billion | 754.14 Million | 946.19 Million | 920.55 Million | 859.62 Million | 824.04 Million |
| Investing Cash Flow | -1.22 Billion | -133.68 Million | 47.72 Million | -101.71 Million | -90.98 Million | -125.94 Million |
| Investments in PPE | -445.16 Million | -127.7 Million | -184.14 Million | -43.96 Million | -111.65 Million | -154.33 Million |
| Acquisitions | 29.46 Million | 1.44 Million | 54.98 Million | - | 3.71 Million | 5.12 Million |
| Investment purchases | -811.2 Million | -12.73 Million | -226.25 Million | -62.87 Million | -14.79 Million | -2.47 Million |
| Sales/Maturities of investments | - | 11.28 Million | 171.26 Million | - | 11.08 Million | -2.65 Million |
| Other Investing Activities | 1000.00 | -5.97 Million | 231.87 Million | 5.12 Million | 20.67 Million | 28.39 Million |
| Financing Cash Flow | 9.04 Billion | -1.85 Billion | -1.4 Billion | -1.23 Billion | -1.33 Billion | 996.24 Million |
| Debt repayment | -305.69 Million | -459.08 Million | -360.11 Million | -398.52 Million | -657.42 Million | -3.38 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 5.2 Million |
| Other Financing Activities | 9.35 Billion | -1.39 Billion | -1.04 Billion | -838.94 Million | -675.16 Million | 4.37 Billion |
| Accounts receivables | -1.12 Billion | -366.78 Million | -261.76 Million | -384.54 Million | -383.95 Million | 131.37 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 328.86 Million | -101.02 Million | -528.33 Million | -328.48 Million | -262.08 Million | -122.77 Million |
| Other working capital | -4.1 Billion | -45.44 Million | -89.06 Million | 88.94 Million | 335.91 Million | -2.27 Billion |
| Cash at beginning of period | 180.45 Million | 214.77 Million | 116 Million | 105.82 Million | 299.68 Million | 94.47 Million |
| Cash at end of period | 4.31 Billion | 170.71 Million | 257.7 Million | 116.11 Million | 128.48 Million | 322.06 Million |
| Capital Expenditure | -445.16 Million | -127.7 Million | -184.14 Million | -43.96 Million | -111.65 Million | -154.33 Million |
| Effect of forex changes on cash | - | -42.92 Million | -104 Thousand | -22.66 Million | -22.38 Million | -3.85 Million |
| Net cash flow / Change in cash | 4.13 Billion | -44.06 Million | 141.69 Million | 10.28 Million | -171.19 Million | 227.59 Million |
| Free Cash Flow | -3.94 Billion | 1.81 Billion | 1.31 Billion | 1.3 Billion | 1.14 Billion | -797 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.38 Billion | 4.2 Billion | 194.18 Million | 316.56 Million | 172.42 Million | 1.13 Billion |
| Depreciation & Amortization | - | 533.02 Million | 135.55 Million | 131.87 Million | 138.85 Million | 573.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -4.89 Billion | - | - | - | -513.25 Million |
| Other non-cash items | -2.38 Billion | -1.48 Billion | -194.18 Million | -316.56 Million | -172.42 Million | 754.14 Million |
| Investing Cash Flow | - | -1.22 Billion | - | - | - | -133.68 Million |
| Investments in PPE | - | -445.16 Million | - | - | - | -127.7 Million |
| Acquisitions | - | 29.46 Million | - | - | - | 1.44 Million |
| Investment purchases | - | -811.2 Million | - | - | - | -12.73 Million |
| Sales/Maturities of investments | - | - | - | - | - | 11.28 Million |
| Other Investing Activities | - | 1000.00 | - | - | - | -5.97 Million |
| Financing Cash Flow | - | 9.04 Billion | - | - | - | -1.85 Billion |
| Debt repayment | - | -305.69 Million | - | - | - | -459.08 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 9.35 Billion | - | - | - | -1.39 Billion |
| Accounts receivables | - | -1.12 Billion | - | - | - | -366.78 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | 328.86 Million | - | - | - | -101.02 Million |
| Other working capital | - | -4.1 Billion | - | - | - | -45.44 Million |
| Cash at beginning of period | - | 180.45 Million | 132.04 Million | -131.7 Million | 180.45 Million | 214.77 Million |
| Cash at end of period | - | 4.31 Billion | 403.16 Million | 132.04 Million | 458.16 Million | 170.71 Million |
| Capital Expenditure | - | -445.16 Million | - | - | - | -127.7 Million |
| Effect of forex changes on cash | - | - | - | - | - | -42.92 Million |
| Net cash flow / Change in cash | - | 4.13 Billion | 271.11 Million | 263.75 Million | 277.7 Million | -44.06 Million |
| Free Cash Flow | - | -3.94 Billion | 271.11 Million | 263.75 Million | 277.7 Million | 1.81 Billion |
PAZA
CARE
0026
CSSPF
SNEGF
RIPLEY